BE Board:Industrial seminar series
For current website see begradboard.mit.edu
Upcoming SpeakersSeptember 23, 2005 - * Special Bioethics Seminar * Stempsey (College of Holy Cross) October 28, 2005 - * Special Bioethics Seminar * Thomas Shannon (Worcester Polytechnic Institute) December 2, 2005 Mark Trusheim (Massachusetts Biotechnology Council) - 56-114 1:30 - 2:30 pm Past Speakers
Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"
Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"
Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"
Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"
John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"
Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"
Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"
Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"
Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"
Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"
Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.) "Starting a career in industry as an MIT alum"
Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"
Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering" |